Search research articles
Contact Us
Filters
Showing results (671-680 of 685) with videos related to
Page
of 69
Sort By:
Breast Cancer Research and Treatment
|
February 21, 2024
Time trends in real-world treatment patterns and survival in patients diagnosed with de novo HER2+ metastatic breast cancer: an analysis of the SONABRE registry
Sandra M E Geurts, Khava I E Ibragimova, Nan Ding, et al.
Neuro-Oncology
|
December 26, 2024
The role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant glioma
Macarena I de la Fuente, Mehdi Touat, Martin J van den Bent, et al.
The New England Journal of Medicine
|
June 5, 2023
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma
Ingo K Mellinghoff, Martin J van den Bent, Deborah T Blumenthal, et al.
Neuro-Oncology Advances
|
May 19, 2021
The state of neuro-oncology during the COVID-19 pandemic: a worldwide assessment
Maciej M Mrugala, Quinn T Ostrom, Shelley M Pressley, et al.
Journal of the National Cancer Institute
|
April 11, 2023
Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma
Kristen Spencer, Leontios Pappas, Islam Baiev, et al.
JCO Precision Oncology
|
August 10, 2023
The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma
Leontios Pappas, Islam Baiev, Stephanie Reyes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 22, 2021
Lutetium-177-PSMA-617 in Low-Volume Hormone-Sensitive Metastatic Prostate Cancer: A Prospective Pilot Study
Bastiaan M Privé, Steffie M B Peters, Constantijn H J Muselaers, et al.
The Lancet. Oncology
|
November 1, 2025
Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a randomised, double-blind, placebo-controlled, phase 3 trial
Timothy F Cloughesy, Martin J van den Bent, Mehdi Touat, et al.
Ecology Letters
|
November 2, 2025
Sex Drives Intraspecific Scaling of Home Range Size in Mammals
Aline Giroux, Denis Valle, Eliezer Gurarie, et al.
BMC Cancer
|
September 6, 2022
Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk ("ugly") locally advanced rectal cancer: study protocol of a single-arm, multicentre, open-label, phase II trial (MEND-IT)
K van den Berg, D P Schaap, E L K Voogt, et al.
Page
of 69
Search research articles
Search
Showing results (671-680 of 685) with videos related to
Sort By:
Page
of 69
Breast Cancer Research and Treatment
|
February 21, 2024
Time trends in real-world treatment patterns and survival in patients diagnosed with de novo HER2+ metastatic breast cancer: an analysis of the SONABRE registry
Sandra M E Geurts, Khava I E Ibragimova, Nan Ding, et al.
Neuro-Oncology
|
December 26, 2024
The role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant glioma
Macarena I de la Fuente, Mehdi Touat, Martin J van den Bent, et al.
The New England Journal of Medicine
|
June 5, 2023
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma
Ingo K Mellinghoff, Martin J van den Bent, Deborah T Blumenthal, et al.
Neuro-Oncology Advances
|
May 19, 2021
The state of neuro-oncology during the COVID-19 pandemic: a worldwide assessment
Maciej M Mrugala, Quinn T Ostrom, Shelley M Pressley, et al.
Journal of the National Cancer Institute
|
April 11, 2023
Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma
Kristen Spencer, Leontios Pappas, Islam Baiev, et al.
JCO Precision Oncology
|
August 10, 2023
The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma
Leontios Pappas, Islam Baiev, Stephanie Reyes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 22, 2021
Lutetium-177-PSMA-617 in Low-Volume Hormone-Sensitive Metastatic Prostate Cancer: A Prospective Pilot Study
Bastiaan M Privé, Steffie M B Peters, Constantijn H J Muselaers, et al.
The Lancet. Oncology
|
November 1, 2025
Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a randomised, double-blind, placebo-controlled, phase 3 trial
Timothy F Cloughesy, Martin J van den Bent, Mehdi Touat, et al.
Ecology Letters
|
November 2, 2025
Sex Drives Intraspecific Scaling of Home Range Size in Mammals
Aline Giroux, Denis Valle, Eliezer Gurarie, et al.
BMC Cancer
|
September 6, 2022
Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk ("ugly") locally advanced rectal cancer: study protocol of a single-arm, multicentre, open-label, phase II trial (MEND-IT)
K van den Berg, D P Schaap, E L K Voogt, et al.
Page
of 69